Free Trial

TFF Pharmaceuticals (TFFP) Competitors

TFF Pharmaceuticals logo
$0.06 0.00 (0.00%)
As of 03/28/2025

TFFP vs. TRVN, PTEIQ, NMTR, EVFM, TNFA, VIRX, MYMD, AEON, PTPI, and ATXI

Should you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include Trevena (TRVN), PolarityTE (PTEIQ), 9 Meters Biopharma (NMTR), Evofem Biosciences (EVFM), TNF Pharmaceuticals (TNFA), Viracta Therapeutics (VIRX), MyMD Pharmaceuticals (MYMD), AEON Biopharma (AEON), Petros Pharmaceuticals (PTPI), and Avenue Therapeutics (ATXI). These companies are all part of the "pharmaceutical products" industry.

TFF Pharmaceuticals vs.

Trevena (NASDAQ:TRVN) and TFF Pharmaceuticals (NASDAQ:TFFP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability.

TFF Pharmaceuticals has lower revenue, but higher earnings than Trevena. Trevena is trading at a lower price-to-earnings ratio than TFF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trevena$443K2.44-$40.29M-$47.04-0.03
TFF Pharmaceuticals-$70.98K-4.07-$21.24M-$6.44-0.01

Trevena received 549 more outperform votes than TFF Pharmaceuticals when rated by MarketBeat users. Likewise, 68.75% of users gave Trevena an outperform vote while only 67.68% of users gave TFF Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
TrevenaOutperform Votes
616
68.75%
Underperform Votes
280
31.25%
TFF PharmaceuticalsOutperform Votes
67
67.68%
Underperform Votes
32
32.32%

In the previous week, Trevena had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 1 mentions for Trevena and 0 mentions for TFF Pharmaceuticals. Trevena's average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Trevena Neutral
TFF Pharmaceuticals Neutral

Trevena has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, TFF Pharmaceuticals has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

Trevena presently has a consensus target price of $5.00, suggesting a potential upside of 300.00%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than TFF Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trevena
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
TFF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Trevena has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,596.64%. Trevena's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TrevenaN/A N/A -119.55%
TFF Pharmaceuticals -1,596.64%-310.17%-196.06%

13.6% of Trevena shares are owned by institutional investors. Comparatively, 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 2.7% of Trevena shares are owned by company insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Trevena beats TFF Pharmaceuticals on 10 of the 16 factors compared between the two stocks.

Remove Ads
Get TFF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFFP vs. The Competition

MetricTFF PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$289,000.00$6.90B$5.63B$7.84B
Dividend YieldN/A2.76%5.33%4.01%
P/E Ratio-0.017.2623.5518.73
Price / Sales-4.07218.61388.1990.75
Price / CashN/A65.6738.1734.64
Price / Book0.026.386.894.23
Net Income-$21.24M$142.34M$3.20B$247.47M
7 Day PerformanceN/A-5.15%-3.06%-2.29%
1 Month PerformanceN/A-7.55%1.51%-5.81%
1 Year PerformanceN/A-11.06%9.37%-0.96%

TFF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFFP
TFF Pharmaceuticals
N/A$0.07
flat
N/AN/A$289,000.00$-70,983.00-0.0119
TRVN
Trevena
0.8103 of 5 stars
$1.28
-3.0%
$5.00
+290.6%
-89.1%$1.11M$443,000.00-0.0340Analyst Forecast
News Coverage
PTEIQ
PolarityTE
N/A$0.15
flat
N/A+50.3%$1.10M$810,000.00-0.0560
NMTR
9 Meters Biopharma
N/AN/AN/AN/A$1.04MN/A-0.0220
EVFM
Evofem Biosciences
0.4967 of 5 stars
$0.01
-11.0%
N/A-59.3%$1.01M$11.39M-0.01120News Coverage
Gap Down
TNFA
TNF Pharmaceuticals
N/A$0.36
-4.2%
N/AN/A$995,000.00N/A0.006Gap Down
VIRX
Viracta Therapeutics
1.1519 of 5 stars
$0.02
-8.4%
$4.05
+17,585.6%
-97.5%$910,000.00N/A-0.0220
MYMD
MyMD Pharmaceuticals
N/A$0.38
+3.4%
N/A-84.9%$893,000.00N/A0.006Gap Down
AEON
AEON Biopharma
1.7297 of 5 stars
$0.72
+8.0%
$360.00
+49,637.5%
-99.9%$805,000.00N/A4.025Upcoming Earnings
News Coverage
Gap Down
PTPI
Petros Pharmaceuticals
0.3808 of 5 stars
$0.07
-2.7%
N/A-94.2%$804,000.00$4.02M-0.0120Short Interest ↑
Gap Down
High Trading Volume
ATXI
Avenue Therapeutics
2.9261 of 5 stars
$0.36
-0.6%
N/A-97.2%$739,000.00N/A0.024
Remove Ads

Related Companies and Tools


This page (NASDAQ:TFFP) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners